Terms: = Pancreatic cancer AND ATP2B3, PMCA3, 492, ENSG00000067842
84 results:
1. Effect of comprehensive nursing care for the liver cancer patients undergoing interventional therapy in China: A systematic review and meta-analysis.
Zhang S; Li N; Mao X; Yang D
Int J Nurs Pract; 2024 Apr; 30(2):e13243. PubMed ID: 38351900
[TBL] [Abstract] [Full Text] [Related]
2. [Robotic and Laparoscopic pancreaticoduodenectomy for the Elderly Patients-A Single Institutional Experience].
Takeda Y; Ohmura Y; Katsura Y; Shinke G; Kinoshita M; Aoyama S; Kihara Y; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1688-1690. PubMed ID: 38303174
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of tertiary lymphoid structures (TLS) in digestive system cancers: a systematic review and meta-analysis.
Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
[TBL] [Abstract] [Full Text] [Related]
4. The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma.
Chang JH; Hossain MS; Stackhouse K; Dahdaleh F; Denbo J; Augustin T; Simon R; Joyce D; Matthew Walsh R; Naffouje S
HPB (Oxford); 2023 Oct; 25(10):1213-1222. PubMed ID: 37357114
[TBL] [Abstract] [Full Text] [Related]
5. Glucagon-Like Peptide 1-Based Therapies and Risk of pancreatic cancer in Patients With Diabetes and Obesity.
Krishnan A; Hadi Y; Hutson WR; Thakkar S; Singh S
Pancreas; 2022 Nov-Dec 01; 51(10):1398-1403. PubMed ID: 37099785
[TBL] [Abstract] [Full Text] [Related]
6. NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.
Liu S; He X; Di Y; Li Q; Li F; Ma Y; Chen L; Gao Y; Xu J; Yang S; Xu L; Corpe C; Ling Y; Zhang X; Xu J; Yu W; Wang J
Carcinogenesis; 2023 May; 44(2):153-165. PubMed ID: 36591938
[TBL] [Abstract] [Full Text] [Related]
7. Association of Adjuvant Chemotherapy in Patients With Resected pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy.
Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M
JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190
[TBL] [Abstract] [Full Text] [Related]
8. Intraductal Papillary Mucinous Neoplasm Arising from Heterotopic Pancreas in Stomach: A Case Report and Review of Literature.
Pang Y; Liu Y; Liu Q; Hou G
Int J Surg Pathol; 2023 Aug; 31(5):708-713. PubMed ID: 35946106
[TBL] [Abstract] [Full Text] [Related]
9. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable pancreatic Ductal Adenocarcinoma.
Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
[TBL] [Abstract] [Full Text] [Related]
10. [Preliminary evaluation on the efficacy of emergency transcatheter aortic valve replacement: a multicenter study].
Zhou Z; Zhang LY; Yang J; Shang XK; Li J; Pan WZ; Jiang ZM; Fang ZF; Li F; Wu YJ; Song GY
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):698-704. PubMed ID: 35856227
[No Abstract] [Full Text] [Related]
11. Effects of body mass index and serum albumin on overall survival in patients with cancer undergoing pancreaticoduodenectomy: a single-center retrospective cohort study.
Cui L; Yu H; Sun Q; Miao Y; Jiang K; Fang X
World J Surg Oncol; 2022 Jul; 20(1):221. PubMed ID: 35773692
[TBL] [Abstract] [Full Text] [Related]
12. Rate of pancreatic cancer following a negative endoscopic ultrasound and associated factors.
King D; Kamran U; Dosanjh A; Coupland B; Mytton J; Leeds JS; Nayar M; Patel P; Oppong KW; Trudgill NJ
Endoscopy; 2022 Nov; 54(11):1053-1061. PubMed ID: 35359019
[TBL] [Abstract] [Full Text] [Related]
13. Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach.
Carbone F; Chee Y; Rasheed S; Cunningham D; Bhogal RH; Jiao L; Tekkis P; Kontovounisios C
Updates Surg; 2022 Apr; 74(2):451-465. PubMed ID: 35040077
[TBL] [Abstract] [Full Text] [Related]
14. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract] [Full Text] [Related]
15. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.
Liu Z; Lin C; Suo C; Zhao R; Jin L; Zhang T; Chen X
Metabolism; 2022 Feb; 127():154955. PubMed ID: 34915036
[TBL] [Abstract] [Full Text] [Related]
16. Changes in Metabolic Syndrome Status are Associated With Altered Risk of pancreatic cancer: A Nationwide Cohort Study.
Park JH; Han K; Hong JY; Park YS; Hur KY; Kang G; Park JO
Gastroenterology; 2022 Feb; 162(2):509-520.e7. PubMed ID: 34653420
[TBL] [Abstract] [Full Text] [Related]
17. [Prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric cancer].
Wang TB; Zhou H; Zhang XJ; Sun CY; Guo CG; Chen YT; Zhou AP; Jin J; Zhao DB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Aug; 43(4):571-578. PubMed ID: 34494528
[TBL] [Abstract] [Full Text] [Related]
18. Predictors of survival rate in patients with pancreatic cancer: A multi-center analytical study in Iran.
Bahardoust M; Abyazi MA; Emami SA; Ghadimi P; Khodabandeh M; Mahmoudi F; Hosseinzadeh R; Heiat M; Agah S
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1547. PubMed ID: 34494396
[TBL] [Abstract] [Full Text] [Related]
19. Baseline HBV-DNA load plus AST/ALT ratio predicts prognosis of HBV-related hepatocellular carcinoma after hepatectomy: A multicentre study.
Shen J; Dai J; Zhang Y; Xie F; Yu Y; Li C; Wen T
J Viral Hepat; 2021 Nov; 28(11):1587-1596. PubMed ID: 34464991
[TBL] [Abstract] [Full Text] [Related]
20. Pharmacoeconomic Evaluation of Erlotinib for the Treatment of pancreatic cancer.
Bao K; Li X; He X; Jian L
Clin Ther; 2021 Jun; 43(6):1107-1115. PubMed ID: 34059328
[TBL] [Abstract] [Full Text] [Related]
[Next]
